Exodus Point Capital Management, LP Harvard Bioscience Inc Transaction History

Exodus Point Capital Management, LP

  • $14.7 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$6.37 - $8.18 $100,639 - $129,235
-15,799 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$6.98 - $8.47 $10,770 - $13,069
1,543 Added 10.82%
15,799 $110,000
Q2 2021

Aug 16, 2021
BUY
$5.44 - $8.4 $77,552 - $119,750
14,256 New
14,256 $119,000
Q3 2019

Nov 14, 2019
SELL
$1.59 - $3.47 $15,982 - $34,880
-10,052 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$1.93 - $4.59 $19,400 - $46,138
10,052 New
10,052 $20,000

Others Institutions Holding HBIO

# of Institutions
103
Shares Held
32M
Call Options Held
1.2K
Put Options Held
1.2K
View Full List

About HARVARD BIOSCIENCE INC

HBIO Quotes by TradingView
  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $102M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email